Umeå University, Medicinska fakulteten

Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.

The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.

Are you interested in learning more? Read about Umeå university as a workplace

The Faculty of Medicine, which consists of 13 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.

Work tasks
To design and execute analyses of the role of the Ide gene in mouse beta cells using in vivo and ex vivo analyses of beta cell function by comparing Ide mutant mice and Ide rescue mice using wt and mutant Ide transgenes. The in vivo analyses includes glucose tolerance tests and analyses of insulin and glucagon secretion. The ex vivo analyses of insulin content, gene and protein expression etc. To analyze RNA seq data comparing Ide wt and mutant islets and to compile data for publication including writing papers.

Qualifications 
Ph.D. exam. in biology or molecular medicine. Experience from metabolic analyses of genetically modified mice is required. The applicant should be proficient in written and spoken English. Applicants with documented expertise in beta cell biology, including in vivo and in vitro studies of insulin secretion, are prioritized.  

The successful candidates are expected to design and execute his or her project independently but also to work in close collaboration with the other members of the research group.

Terms
Full time, fixed time employment until 2019-06-30.

Type of employment Special fixed-term employment
Employment expires 2019-06-30
Contract type Full time
First day of employment 2019-03-17
Salary Monthly salary
Number of positions 1
Full-time equivalent 100%
City Umeå
County Västerbottens län
Country Sweden
Reference number AN 2.2.1-178-19
Contact
  • Helena Edlund, professor, helena.edlund@umu.se, 090-786 67 99
Union representative
  • SACO, 090-786 53 65
  • SEKO, 090-786 52 96
  • ST, 090-786 54 31
Published 05.Feb.2019
Last application date 17.Feb.2019 11:59 PM CET

Return to job vacancies